UK Markets closed

Titan Medical Inc. (TMDI)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.6100-0.0580 (-8.68%)
At close: 04:00PM EST
0.6400 +0.03 (+4.92%)
After hours: 07:27PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 4.65
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 33.4700
52-week low 30.6000
50-day moving average 31.3310
200-day moving average 31.6316

Share statistics

Avg vol (3-month) 3690k
Avg vol (10-day) 3991.03k
Shares outstanding 5109.53M
Implied shares outstanding 6N/A
Float 8110.85M
% held by insiders 10.25%
% held by institutions 13.44%
Shares short (14 Sept 2021) 42.24M
Short ratio (14 Sept 2021) 46.45
Short % of float (14 Sept 2021) 42.02%
Short % of shares outstanding (14 Sept 2021) 42.02%
Shares short (prior month 12 Aug 2021) 42.53M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 318 Jun 2018
Ex-dividend date 4N/A
Last split factor 21:30
Last split date 318 Jun 2018

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Jun 2021


Profit margin -189.16%
Operating margin (ttm)-75.30%

Management effectiveness

Return on assets (ttm)-20.40%
Return on equity (ttm)-221.57%

Income statement

Revenue (ttm)20.09M
Revenue per share (ttm)0.22
Quarterly revenue growth (yoy)0.40%
Gross profit (ttm)20M
EBITDA -14.91M
Net income avi to common (ttm)-38.01M
Diluted EPS (ttm)-0.4760
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)55.01M
Total cash per share (mrq)0.5
Total debt (mrq)3.44M
Total debt/equity (mrq)10.68
Current ratio (mrq)2.10
Book value per share (mrq)0.27

Cash flow statement

Operating cash flow (ttm)-18.63M
Levered free cash flow (ttm)-11.52M